Trexquant Investment’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
Other funds holding ALDR
RG
BG
FCM
CC
DKCM
AAM
PCM
Trexquant Investment's ALDR Position: Q3 2019 in Review
Trexquant Investment sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 19,637 shares — an estimated $231K sold.
Trexquant Investment first reported a position in ALDR in Q1 2015 and held it in 7 quarters. The position peaked at $1.74M in Q3 2015. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.
- Trexquant Investment reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
- Trexquant Investment sold 19,637 Alder Biopharmaceuticals shares in Q3 2019, an estimated $231K.
- Trexquant Investment first reported a position in Alder Biopharmaceuticals in Q1 2015 and held it in 7 quarters.
- Trexquant Investment's Alder Biopharmaceuticals position peaked at $1.74M in Q3 2015.
- 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.
Based on Trexquant Investment's 13F filing for Q3 2019, filed 8 Nov 2019.